Marchex (NASDAQ:MCHX) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Marchex (NASDAQ:MCHX) released its earnings results on Wednesday. The technology company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02), FiscalAI reports. Marchex had a negative net margin of 11.15% and a negative return on equity of 14.32%. The company had revenue of $10.62 million during the quarter, compared to the consensus estimate of $10.89 million.

Here are the key takeaways from Marchex’s conference call:

• Marchex said it believes it is at a positive inflection point, with better execution, rising penetration in its customer base, and early signs that its AI strategy is creating sales momentum.
• The company reported Q1 2026 revenue of $10.6 million, with new sales and upsells partly offset by migration-related revenue pressure from moving legacy platforms to Marchex Engage.
• Management raised near-term expectations, guiding Q2 adjusted EBITDA to $1.6 million-$1.8 million and saying Q3 could reach about $2 million or more on a standalone basis, or $2.5 million or more if the Archenia deal closes.
• Marchex and Archenia are already jointly selling early AI-based products, and management said nearly half of the top customers pitched have already bought one or more offerings on a recurring or pilot basis.
• The company expects the pending Archenia acquisition to close in July 2026, pending stockholder approval, and says the combination could expand its addressable market, lift margins, and support a longer-term revenue run rate of about $60 million annually.

Marchex Price Performance

MCHX stock remained flat at $1.62 during midday trading on Friday. The company had a trading volume of 1,018 shares, compared to its average volume of 16,206. The firm has a market capitalization of $71.13 million, a price-to-earnings ratio of -14.73 and a beta of 1.95. Marchex has a 52-week low of $1.32 and a 52-week high of $2.31. The stock’s 50 day simple moving average is $1.56 and its 200-day simple moving average is $1.61.

Wall Street Analyst Weigh In

MCHX has been the subject of several research reports. Weiss Ratings reiterated a “sell (d-)” rating on shares of Marchex in a research note on Tuesday, April 21st. Zacks Research upgraded shares of Marchex from a “strong sell” rating to a “hold” rating in a research note on Thursday, February 12th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce”.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. XTX Topco Ltd bought a new position in Marchex during the fourth quarter worth about $26,000. Jane Street Group LLC bought a new position in shares of Marchex during the first quarter valued at $30,000. Manatuck Hill Partners LLC bought a new position in shares of Marchex during the second quarter valued at $88,000. Finally, Kanen Wealth Management LLC bought a new position in shares of Marchex during the first quarter valued at $813,000. Institutional investors own 73.46% of the company’s stock.

About Marchex

Marchex, Inc (NASDAQ: MCHX) operates a call data and analytics platform designed to help businesses measure and optimize customer interactions. The company’s core services include call tracking, conversational analytics and performance marketing solutions that attribute phone calls to specific advertising campaigns. By capturing and analyzing voice interactions, Marchex enables advertisers, agencies and brands to gain actionable insights into caller intent, marketing ROI and customer behavior.

Through its suite of technologies, Marchex offers real-time call monitoring, keyword spotting and AI-driven transcription to surface trends and conversion signals from inbound calls.